Skip to Content
Matthews & Associates Matthews & Associates
NATIONWIDE SERVICE 888-923-7001
Top

Thousands Sue Over Shingles Vaccine Injuries

Timely Insights on Laws, Issues and New Developements
|
ShinglesThousands of people injured by the Zostavax vaccine for shingles are suing Merck in Shingles Vaccine Lawsuits. The company that makes Zostavax has caused worse complications than shingles itself. “Side effects” from Merck’s singles vaccine include shingles, meningitis, encephalitis, stroke, palsy, eye injuries, and many others.

Zostavax was approved by the Centers for Disease Control and Prevention (CDC) despite a dearth of convincing efficacy tests. The CDC has since recommended that only those 60 and older should take the vaccine. The FDA, by contrast, approved it for people 50 and older. The CDC has also warned that those aged 50 – 59 may lose the protective benefits of the vaccine by the time they reach 60.

People in their 60s are at the greatest risk of getting shingles, which is why the CDC recommends it for that age group. Meanwhile, the vaccine’s labeling does not make clear how long an injection might last (if it works at all, which is an open question). The CDC recommends that people don’t get the shot until they are at least 60,  because that’s probably when they are going to need it the most.

Shingles Vaccine Injury Lawyer

Attorney David Matthews, whose law firm is handling shingles cases, said injuries from the Zostavax vaccine are many and varied. Shingles vaccine injuries can vary from a person’s contracting shingles to going blind in one eye, suffering brain damage or paralysis in the extremities, or even dying.

Mr. Matthews said, “Merck failed to warn about Zostavax’ serious side effects and the vaccine doesn’t do what Merck claims it does.”

RELATED

  • Shingles Vaccine Lawsuit
FacebookTwitterShare

by Matthews & Associates

Share To:
Locations (By Appt. Only)
  • Houston, TX - Principal Office
    2905 Sackett St.
    Houston, TX 77098
    Map & Directions
  • New York, NY
  • Salinas, CA
Follow Us